查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
Q Fever市场:现况分析与预测（2022-2028）
市场调查报告书
商品编码
1346718

Q Fever市场:现况分析与预测（2022-2028）

Q Fever Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 151 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计 Q 热市场在预测期内将以 5% 的复合年增长率成长。

Q 热疾病盛行率的上升正在推动全球 Q 热市场的成长。 例如，根据疾病与控制中心 2021 年的报告，2019 年报告了约 178 例急性 Q 热病例和 34 例慢性 Q 热病例。 此外，农业、农民、资深医师、动物研究人员等高风险职业接触病菌的风险也很高。 此外，免疫系统较弱或较弱的人在不久的将来患Q热的风险很高。 因此，这些因素预计将在预测期内提振 Q 热市场。

Q热市场依类型分为急性Q热和慢性Q热。 其中，急性 Q 热细分市场预计在预测期内将以大幅复合年增长率成长。 这是因为与慢性 Q 热相比，急性 Q 热的盛行率增加。 例如，根据疾病与控制中心 2021 年的报告，2019 年美国报告了约 178 例急性 Q 热病例。 因此，随着急性Q热发生率的上升，这一细分市场预计将显着成长。

市场依药物治疗分为抗生素、抗疟药、皮质类固醇药物等。 其中，抗生素领域预计将以较大的复合年增长率成长。 抗生素可有效治疗 Q 热引起的细菌感染。 抗生素是首选药物，因为它们有助于减轻症状并缩短病程。

根据最终用户，市场分为医院、诊所和研究机构。 其中，医院产业预计在预测期内将以较大的复合年增长率成长。 医院在 Q 热感染的早期发现和管理方面发挥关键作用，有助于预防严重併发症并减轻医疗保健系统的整体疾病负担。 因此，这个因素正在推动对医院的需求。

为了更了解行为健康产业的市场采用情况，市场包括北美（美国、加拿大、北美其他地区）、欧洲（英国、德国、法国、义大利、西班牙、欧洲其他地区）、亚太地区（中国） 、日本、印度、韩国等亚太地区）以及世界其他地区。 预计亚太地区在预测期内将以显着的复合年增长率成长。 印度是农业中心，该部门对各国的经济和就业做出了重大贡献。 此外，在牛、水牛、羊等牲畜丰富的地区，这些动物也可能成为传染源。 这些动物是伯内特柯克斯体感染的潜在来源。 为了遏制 Q 热在农业领域的传播，政府可能会采取某些措施来教育人们提高对这种疾病的认识。

目录

第 1 章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第 2 章研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第 3 章市场总结

第 4 章执行摘要

第 5 章新型冠状病毒感染（COVID-19）对全球Q热市场的影响

第 6 章2020-2028年全球Q发烧市场收入

第 7 章按类型划分的市场洞察

  • 急性Q热
  • 慢性Q热

第 8 章按药品类型划分的市场洞察

  • 抗生素
  • 抗疟疾
  • 皮质类固醇
  • 其他

第 9 章最终使用者的市场洞察

  • 医院
  • 诊所
  • 调查机构

第 10 章按地区划分的市场洞察

  • 北美市场
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太市场
    • 中国
    • 日本
    • 印度
    • 韩国
    • 亚太地区的其他国家/地区
  • 世界其他地区的市场

第 11 章 Q 热力市场动态

  • 市场驱动因素
  • 市场挑战
  • 影响分析

第 12 章Q发烧市场机会

第 13 章Q发烧市场趋势

第 14 章需求面与供给面分析

  • 需求方分析
  • 供给面分析

第 15 章策略洞察

第 16 章竞争场景

  • 竞争状况
    • 波特五力分析

第 17 章公司简介

  • Sun Pharmaceutical Industries Ltd.
  • Abbott.
  • Aurobindo Pharma.
  • Pfizer Inc.
  • Lupin.
  • Bayer AG
  • Novartis Pharmaceuticals Corporation
  • GSK plc.
  • Merck & Co., Inc.,
  • Sanofi

第 18 章免责声明

简介目录
Product Code: UMHE212179

Q Fever is an infectious disease caused by coxiella burneti. This bacteria is naturally present in some animals including cattle, goats and sheep. Coxiella burnet bacteria are found in the birth products (placenta, amminotic fluids) and in the body secretions such as urine, faecal matter and milk of infected animals. This is a communicable disease and can be transmitted from infected animals to the human being through contaminated dust particles. High-risk occupations including farming, veterinarian doctors and researchers are more susceptible to getting Q fever. Symptoms of Q fever include chills, cough, fever and nausea. Q fever is treated with antibiotics.

The Q Fever Market is anticipated to grow with the CAGR of 5% in the forecasted period.

The rising prevalence of Q fever disease is driving the market growth for Q fever globally. For instance, according to the Centre for Disease and Control, 2021 report, In 2019, around 178 cases of acute Q fever were reported and approximately 34 cases of chronic Q fever. Additionally, high-risk occupations such as agriculture, farmers, veteran doctors and animal researchers are at a higher risk of exposure to the bacteria. Further, people with low immunity or compromised immunity are at a higher risk to develop Q fever in the near future. Thus, these above-mention elements are anticipated to boost the market for Q fever in the forecasting period.

Based on the type the Q fever market is bifurcated into acute Q fever and chronic Q fever. Among these, the acute Q fever segment is anticipated to grow with a significant CAGR in the forecasted period. This is attributed to the rising prevalence of acute Q fever cases on contrary to chronic. For instance, according to the Centre for Disease and Control, 2021 report, In 2019, around 178 cases of acute Q fever cases were reported in the united states. Thus, with the rising incidence of acute Q fever, this segment is anticipated to grow significantly.

Based on the medication the market is segmented into antibiotics, antimalarial, corticosteroids and others. Amongst these, the antibiotics segment is anticipated to grow with a significant CAGR. antibiotics are effective in treating the bacterial infections that can occur as a result of Q fever. Antibiotics can help to reduce symptoms and shorten the duration of the illness, and thus is a preferred choice of drug.

Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period. Hospitals play a crucial role in the early detection and management of Q Fever infections, which can help prevent severe complications and reduce the overall burden of the disease on the healthcare system. Thus, this factor is driving the demand for the hospitals

For a better understanding of the market adoption of the Behavior Health industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. Asia-pacific is anticipated to grow with a significant CAGR during the forecasted period. India is an agricultural hub with a sector contributing significantly to countries economy and employment. Additionally in areas where large no. animals such as cattle, buffalo and sheep. These animals can serve as a reservoir for the Coxiella burnet. To control the spread of Q fever in the agriculture sector the government would take certain initiatives to educate people for spreading awareness regarding the disease.

Some of the major players operating in the market include: Sun Pharmaceutical Industries Ltd., Abbott., Aurobindo Pharma., Pfizer Inc., lupin, Bayers AG, Novartis Pharmaceutical Corporation, GSK plc., Merck & Co.,Inc., Sanofi.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Q Fever Market
  • 2.2. Research Methodology of the Q Fever Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL Q FEVER MARKET COVID-19 IMPACT

6 GLOBAL Q FEVER MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Acute Q Fever
  • 7.2. Chronic Q Fever

8 MARKET INSIGHTS BY MEDICATION TYPE

  • 8.1. Antibiotics
  • 8.2. Antimalerial
  • 8.3. Corticosteroids
  • 8.4. Others

9 MARKET INSIGHTS BY END-USERS

  • 9.1. Hospitals
  • 9.2. Clinics
  • 9.2. Research Institutes

10 MARKET INSIGHTS BY REGION

  • 10.1 North America Market
    • 10.1.1 U.S.
    • 10.1.2 Canada
    • 10.1.3 Rest of North America
  • 10.2 Europe Market
    • 10.2.1 UK
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific Market
    • 10.3.1 China
    • 10.3.2. Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Rest of APAC
  • 10.4 Rest of the World Market

11 Q FEVER MARKET DYNAMICS

  • 11.1 Market Drivers
  • 11.2 Market Challenges
  • 11.3 Impact Analysis

12 Q FEVER MARKET OPPORTUNITIES

13 Q FEVER MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis

15 STRATEGIC INSIGHTS

16 COMPETITIVE SCENARIO

  • 16.1 Competitive Landscape
    • 16.1.1 Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1 Sun Pharmaceutical Industries Ltd.
  • 17.2. Abbott.
  • 17.3 Aurobindo Pharma.
  • 17.4. Pfizer Inc.
  • 17.5. Lupin.
  • 17.6. Bayer AG
  • 17.7. Novartis Pharmaceuticals Corporation
  • 17.8. GSK plc.
  • 17.9. Merck & Co., Inc.,
  • 17.10. Sanofi

18 DISCLAIMER